Nanox AI Subsidiary Signs Distribution Agreement to Commercialize HealthOST in Italy

Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI commercial presence in the Italian market, leveraging Technologic experience and local market knowledge. HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. To view the full press release, visit https://ibn.fm/y9Zro.

The distribution agreement represents a significant step in Nanox's strategy to drive the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. By combining affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace, Nanox aims to enable earlier detection, improved clinical efficiency, and broader access to care. The company's vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond.

For Texas businesses and the broader healthcare industry, this announcement underscores the growing role of AI in diagnostics and preventive care. As companies like Nanox expand their commercial footprint internationally, they demonstrate the scalability of AI-driven solutions that can be adapted to different healthcare systems. The agreement with Technologic s.r.l. not only extends Nanox AI's presence in Italy but also validates the commercial potential of its HealthOST technology, which could inform similar partnerships and adoption in other markets, including the United States.

Nanox's ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery. By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.

The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. For full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published, visit https://IBN.ai/Disclaimer.